Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION (Details 3)

v3.24.3
SHARE-BASED COMPENSATION (Details 3) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares Exercisable at end of period 1,281  
Stock Options [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares Options Outstanding, Beginning 7,812,178  
Exercise Price Outstanding, Beginning $ 3.70  
Weighted Average Remaining Contractual Life (Years) 4 years 10 days [1] 6 years 6 months 21 days
Weighted-Average Grant Date Fair Value,Beginning $ 2.23  
Number of Shares Options Granted 15,000  
Exercise Price Granted $ 0.14  
Weighted-Average Grant Date Fair Value,Granted $ 0.10  
Number of Shares Options, Forfeited (816,872)  
Exercise Price Forfeited $ 2.78  
Weighted-Average Grant Date Fair Value,Forfeited $ 1.61  
Number of Shares Options Expired (1,017,783)  
Exercise Price Expired $ 4.17  
Weighted-Average Grant Date Fair Value,Expired $ 2.23  
Number of Shares Options Outstanding, Ending 5,992,523 [1] 7,812,178
Exercise Price Outstanding, Ending $ 3.74 [1] $ 3.70
Weighted-Average Grant Date Fair Value,Ending $ 1.98 [1] $ 2.23
Number of Shares Exercisable at end of period [2] 5,016,708  
Exercise Price Options exercisable at end of period [2] $ 3.82  
Weighted Average Remaining Contractual Life (Years) exercisable [2] 3 years 2 months 26 days  
Weighted-average grant date fair value exercisable [2] $ 2.02  
[1] There was no aggregate intrinsic value of all stock options outstanding as of December 31, 2023.
[2] There was no aggregate intrinsic value of all vested/exercisable stock options as of December 31, 2023.